scholarly journals Budget Impact Analysis of Ustekinumab for the Treatment of Moderate to Severe Crohn’s Disease from a Brazilian Private Payer Perspective

2018 ◽  
Vol 21 ◽  
pp. S82
Author(s):  
CO Fioratti ◽  
E Asano ◽  
RP Rosim
Keyword(s):  
Crohn’S Disease ◽  
Crohn's Disease ◽  
Impact Analysis ◽  
Budget Impact ◽  
Budget Impact Analysis ◽  
Payer Perspective ◽  
Private Payer

scholarly journals Cost-effectiveness and budget impact analysis of infliximab and its biosimilar in patients with refractory moderate-to-severe Crohn’s disease using real world evidence in Thailand

2020 ◽  
Vol 23 (11) ◽  
pp. 1302-1310
Author(s):  
Pochamana Phisalprapa ◽  
Chayanis Kositamongkol ◽  
Julajak Limsrivilai ◽  
Satimai Aniwan ◽  
Phunchai Charatcharoenwitthaya ◽  
...  
Keyword(s):  
Crohn’S Disease ◽  
Cost Effectiveness ◽  
Crohn's Disease ◽  
Real World ◽  
Impact Analysis ◽  
Budget Impact ◽  
Budget Impact Analysis ◽  
Real World Evidence
Sign in / Sign up

Export Citation Format

Share Document